title: Bisphosphonates may also be effective in the management of non-skeletal metastases in hormone receptor positive breast cancer.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozen
authors.forename: Fatih
authors.initials: F
authors.lastname: Karaahmet
authors.forename: Kadriye
authors.initials: K
authors.lastname: Aydin
authors.forename: Furkan
authors.initials: F
authors.lastname: Sarici
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D019386:Alendronate / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011960:Receptors, Estrogen / Q000032:analysis
chemical_list: D004164:Diphosphonates; D011960:Receptors, Estrogen; D019386:Alendronate